• Sign in
  • Communities
  • BillCam
  • About Us
  • Shop
0
DailyClout

Help fund independent journalism.

Donate
  • Sign In
  • Home
  • Opinion
    • Outspoken
    • The Drew Allen Show on DailyClout
    • Heart & Mind
    • Investigate Everything
    • Emerald & Naomi
    • Generation Rogue
    • The Liberty Lobbyist
    • The Shannon Joy Show on DailyClout
    • Man in America on DailyClout
    • The Sarah Westall Show on DailyClout
  • Submissions
  • Events
  • Our Story
  • Shop
  • Become a Member!
  • Donate

Bulletin Board DailyClout

Ebola Virus Research at Texas Biomed Gets NIH Funding Boost

June 6, 2022 • by Texas Biomed
Ebola virus research at Texas Biomed gets NIH funding boost

https://www.ebolaoutbreakmap.com/listings/ebola-drfauci/

ebola gain of function

 

gain of function

 

Two new grants support research exploring how Ebola virus spreads in the body with implication for targeted viral treatments

SAN ANTONIO (June 17, 2021) – Scientists have a general idea of how viruses invade and spread in the body, but the precise mechanisms are actually not well understood, especially when it comes to Ebola virus. Olena Shtanko, Ph.D., a Staff Scientist at the Texas Biomedical Research Institute (Texas Biomed), has received more than $1 million from the National Institutes of Health (NIH) to explore different aspects of Ebola virus infection. Understanding how cells become infected is critical to identifying and designing therapies that target viral replication and spread in a host.

“The general model of spread of Ebola virus infection where a viral particle infects a cell, replication begins, new virus particles are made and released into the body to infect neighboring cells is probably a bit too simplistic,” said Shtanko, who is part of the Texas Biomed Host-Pathogen Interactions Program. “How does the virus really get from the site of initial infection, penetrate dense tissues, evade the body’s defense system and end up in distant organs, such as the liver, just a few days later? We really don’t know.”

Over the next two years, Shtanko will explore precisely how the Ebola virus hijacks a key immune cell in the body called macrophages. Even though these large cells specialize in detecting and killing harmful invaders, Ebola and other filoviruses have found a way to enter and hide in the cells. The macrophages then help distribute the virus around the body, serving like Trojan horses, through an unknown mechanism. Shtanko will investigate how exactly virus infection transforms migration and invasive properties of macrophages to maximize its spread in the host.

Fluorescent imaging shows tunneling nanotubes connecting human macrophages (blue) infected with Ebola virus (green). Cell nuclei are shown in red. Notably, the virus is visible at numerous points along the nanotubes. Researchers at Texas Biomed will investigate the role tunneling nanotubes play in Ebola virus spread.

Shtanko is also excited to explore a possible alternative mode of spread — tunneling nanotubes, dynamic connections between cells, which allow cells to communicate by exchanging content over relatively long distances (up to 200 microns). While these structures have been shown to play a prominent role in promoting neurodegenerative diseases, cancer, and spread of a variety of viruses, including HIV-1 and influenza, no one is known to have investigated their role in disseminating Ebola and related viruses.

“It is critical to understand if Ebola virus is able to crawl from cell to cell without ever creating new virus particles that move freely in the body, because those free particles are the typical targets for the immune system and pharmaceutical interventions,” Shtanko said.

“Ebola virus might be escaping early detection and perhaps eventually establishing persistent infection by using these nanotubes.”

Such basic research insights can help inform development of more effective anti-viral treatments or vaccines. The research projects will involve cells and tissues infected with Ebola virus – research that can only be safely conducted in the highest level biocontainment laboratories, called BSL4. Texas Biomed is uniquely positioned for this type of research, hosting both a BSL4 lab and the Southwest National Primate Research Center. While this initial research will be in vitro (or in a petri dish), the studies will eventually move to more advanced animal models.

Additionally, Dr. Shtanko is collaborating with several Texas Biomed investigators on these projects: Texas Biomed President/CEO Larry Schlesinger, M.D., a renowned expert on macrophages whose lab studies macrophages and their role in tuberculosis; Professor Andrew Hayhurst, Ph.D., who has engineered novel llama domain antibodies specific for Ebola virus; and Professor Ricardo Carrion, Jr., Ph.D., an expert on development of non-human primate models of Ebola virus disease.

This research is funded by two R21 grants #AI151717 and #AI154336 from the National Institutes of Health National Institute of Allergy & Infectious Diseases.

Spread the Word

Subscribe to DailyClout so you never miss an update!

Spread the Word

  • Please support DailyClout.io. Our research, our uncompromising, fact-based journalism, our compelling opinion pieces and videos, our BillCam platform that lets you pass good bills and stop bad bills, and our lawsuits to preserve medical freedom and secure accountability for wrongdoers, have all helped to keep America and countries around the world safer and freer. We need your donations to keep fighting for you and your loved ones. We cannot do any of it without you and your generous support. Please give what you can as a one-time donation, or please, if you can, send us a monthly recurring donation. Please put resources behind the values you support, and that we do so much to help you defend.

    Thank you.

  • $0.00

ebola nanotubes outbreak san antonio texas biomed
Previous StoryPrinceton Parent Pleads for Students’ Medical Freedom
Next StoryGas Price Pain – We Are Paying Almost $2 More Than A Year Ago

Leave your comment Cancel Reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent Posts

  • Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of strategy (23)
    DOJ Referred Adam Schiff for Alleged Mortgage Fraud Wednesday, 16, Jul
  • Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of strategy (21)
    “THE MAN WHO DISCOVERED THE POTENTIAL CANCER TREATMENT BIG PHARMA DOESN’T WANT YOU TO KNOW ABOUT” (SPONSORED) Wednesday, 16, Jul
  • Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of strategy (20)
    Halting COVID-19 “Vaccine” Trials in the “Non-high-risk” When Benefit is Acknowledged as “Minimal”: A Next Step to Protecting All Children Wednesday, 16, Jul
  • Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of strategy (19)
    EPA to Appeal Court Ruling on Water Fluoridation Risks Wednesday, 16, Jul
  • nationnnnnnnnnnn
    The Fake Victory Parade in Syria Continues Tuesday, 15, Jul

Blog Archive

Subscribe to Our Free Newsletter

  • About Us
  • Advertise With DailyClout
  • Become a Member
  • BillCam
  • Communities
  • Contact Us
  • Donate
  • Submissions
  • Substack
  • Privacy Policy
View Cart Checkout Continue Shopping
Do you really want to logout of DailyClout?
Yes

You are now leaving DailyClout...